Life Sciences Licensing & Strategic Partnering
We represent life sciences innovation companies in every type of strategic and licensing transaction necessary to propel their businesses. We provide clients with advice and counsel on what we know to be the most critical issues on a startup’s road-map.
Our practical advice, technical skill and constant support help prepare clients for eventual partnerships with other pharmaceutical, biotech and medical device companies and venture financings.
Learn More
Life Sciences Licensing & Strategic Partnering
We represent life sciences innovation companies in every type of strategic and licensing transaction necessary to propel their businesses. We provide clients with advice and counsel on what we know to be the most critical issues on a startup’s road-map.
Our practical advice, technical skill and constant support help prepare clients for eventual partnerships with other pharmaceutical, biotech and medical device companies and venture financings.
We advise life sciences companies throughout their growth, from startups to established players, guiding them on critical issues and preparing them for successful partnerships. We leverage our deep industry experience to negotiate win-win collaborations and licensing agreements with major pharmaceutical, biotech, and medical device companies.

Deserved Recognition
LMG Life Sciences Awards
- VC Law Firm of the Year, 2022
- Nominated as VC Law Firm of the Year by LMG for 2021, 2022, 2023 & 2024
- Finance/Transactional Impact Deal of the Year for $1.6B acquisition of client ARMO Biosciences by Eli Lilly
- Four of our partners are recognized as "Transactional Stars"
Related News & Insights
Related News & Insights
Gunderson Dettmer Strategic Transactions and Licensing partner Brendan McCarthy hosted the webinar “’What’s Market’ in University Licenses in the Life Sciences Industry” to discuss the key economic terms in university license agreements.